OOIR: Observatory of International Research

Papers

(The H4-Index of Critical Reviews in Microbiology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	145
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	75
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	66
TREM-2: friend or foe in infectious diseases?	65
EnterohepaticHelicobacterspecies – clinical importance, host range, and zoonotic potential	56
Salmonella in eggs and egg-laying chickens: pathways to effective control	52
Helicobacter pylori infection: from standard to alternative treatment strategies	42
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	40
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	37
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	36
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	36
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	33
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	33
Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions	32
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	32
Biosynthesis, regulation, and biological significance of fumonisins in fungi: current status and prospects	30
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	29
Applications of bacteriophages against intracellular bacteria	27
Exploring halophilic environments as a source of new antibiotics	27
LysR-type transcriptional regulators: state of the art	27
Vibrio cholerae virulence and its suppression through the quorum-sensing system	26
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	26
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	25
Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge	25
Emerging cellular and molecular interactions between the lung microbiota and lung diseases	24

The microbiome and precision oncology: an emerging paradigm in anticancer therapy	24
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	24